NX PharmaGen was founded to invest in technology that has the potential to enrich the lives of patients through the utilization of our revolutionary molecular diagnostics and imaging technologies. Application of our next-generation products are expected to benefit patient outcomes, physician decision making, and payer economics, while also accelerating the testing and approval of new interventions.